Pfizer Ltd.

Just Dial, Pfizer To Be Dropped From BSE 200; Muthoot Finance In

Court Asks Pfizer To Withdraw Drug 6 Months Before Expiry

Advent, Baxter Set To Submit Bids For India's Gland Pharma: Report

Pfizer to Close Plant at Thane

Pfizer Falls on Weak Fourth Quarter Numbers

Pfizer Posts Rs 18 Crore Profit in Q3

Pfizer Announces Completion of Merger With Wyeth

Lupin Gets Regulatory Nod to Market Arthritis Treatment Drug in US

Pfizer Gets Bombay High Court Nod for Merger of Wyeth

Pfizer, Ranbaxy Win Dismissal of Lawsuit Over Generic Lipitor

Appointment

Pfizer Limited has informed the Exchange regarding Appointment of Mr Milind Patil as Chief Financial Officer of the company w.e.f. August 16, 2018.

Clarification sought from Pfizer Ltd

The Exchange has sought clarification from Pfizer Ltd with respect to news article appearing on www.business-standard.com - July 12, 2018 titled "Pfiz...

News Clarification

The Exchange has sought clarification from the Company with respect to news item captioned Pfizers Tamil Nadu facitity not following quality norms In ...

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Listing Regulations, please find attached the details of the meeting scheduled with an Analyst/Institutional Investor...

Analysts

/Institutional Investor Meet

Financial Result Updates

Pfizer Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

Dividend

Pfizer Limited has informed the Exchange that Board of Directors at its meeting held on May 07, 2018, recommended Final Dividend of 20 per equity shar...

Outcome of Board Meeting

Pfizer Limited has informed the Exchange regarding Outcome of Board Meeting held on May 07, 2018.

Press Release

Pfizer Limited has informed the Exchange regarding a press release dated May 07, 2018, titled "Press Release".

Board to consider FY18 results & Dividend on May 07, 2018

Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 07, 2018, inter alia, to consider a...

Board Meeting For The Audited Financial Results For The Financial Year Ended March 31, 2018 And Intimation Of Closure Of Trading Window.

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 7, 2018, inter alia, to consider ...

Compliance Certificate - Regulation 7(3) Of The SEBI (LODR) Regulations, 2015

In compliance with Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate...

Compliance Certificate - Regulation 40 (9) Of The SEBI (LODR) Regulations, 2015

In compliance with Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certifica...

Disc. under Reg.30 of SEBI (SAST) Reg.2011

John Wyeth & Brother Limited, Parke, Davis & Company LLC, Pfizer East India B.V., Pharmacia LLC, Warner-Lambert Company LLC, Wyeth Holdings LLC & Wyet...

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Listing Regulations, enclosed herewith are the details of the meeting scheduled with an Analyst/Institutional Investo...

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Listing Regulations, enclosed herewith are the details of the meeting scheduled with an Analyst/Institutional Investo...

Analysts

/Institutional Investor Meet

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Listing Regulations, enclosed herewith are the details of the meeting scheduled with an Analyst/Institutional Investo...

Analysts

/Institutional Investor Meet

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed press release in connection with the inclusion of certain brands in the global strategic alternatives review for Consumer Healthc...